1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 3:Technical data on staged Onyx embolization
Patient No. No. Embolizations Time Interval Between First, Last Treatment Total Amount of Onyx (in mL) Coils/n-BCA Residual/Cure Treatment for Residual Cumulative X-Ray Skin Entrance Dose (mGy) 1 3 16 d 6.7 GDC and Axium coils PE N/A 2665 2 1 N/A 1.3 GDC-18 3D and Nexus (ev3) coils Cure No treatment, asymptomatic 315 3 3 6 mo 1.3 360-GDC soft coils PE Continued embolizations 1225 4 1 N/A 0.8 None NCE Surgery 624 5 6 9 mo 12.4 GDC-18 NCE Continued embolizations 3708 6 5 7 mo 2.8 GDC coils NCE N/A 3992 7 3 4 mo 2.3 Axium coils NCE If feasible, will re-attempt in 2–3 y 1665 8 1 N/A 1.6 None PE Surgery 657 9 1 N/A 1 None PE Surgery 884 10 5 4 mo 19.9 GDC and Axium coils NCE Surgery 2508 11 1 N/A 2.2 None NCE Surgery 1632 12 1 N/A 1.5 None NCE Surgery 501 13 1 N/A 0.4 None Cure None 537 14 1 N/A 2.1 None NCE Surgery 1956 15 2 2 mo 9.9 None NCE Continued embolization 3907
Note:—PE indicates partial embolization; NCE, near-complete embolization; n-BCA, n-butyl cyanoacrylate; GDC, Guglielmi detachable coil.